In broiler grower and finisher feed manufacturing, narasin premix veterinary grade API is incorporated as a fermentation-derived polyether carboxylic acid ionophore into a micro-ingredient preblend before final feed mixing. Approved in-feed concentrations in major broiler markets fall within 54–72 g/ton of complete feed for the control of coccidiosis caused by Eimeria acervulina, Eimeria tenella, Eimeria maxima, and Eimeria necatrix. The premix concentrate, typically standardised to 90–110 g/kg narasin activity, must be diluted in a two-step sequence when the final in-feed inclusion is below 0.15% w/w. The first dilution is made into a ground corn or rice hull carrier at a ratio of 1:9 or 1:19 in a horizontal ribbon blender with a working volume of 1–3 m³. The second dilution takes place in the main mixer. Blend uniformity is assessed by sampling at 10 points distributed across the mixer dead zones and discharge stream according to ISO 6497:2002. The coefficient of variation for narasin assay should remain at or below 5.0% across 10 samples. Recovery below this threshold in a low-inclusion premix is frequently traced to particle-size mismatch or electrostatic charging of the carrier, not to degradation of the ionophore. The ionophore mechanism involves the formation of lipid-soluble cation complexes that disrupt sodium and potassium gradients in susceptible sporozoite and merozoite stages. This activity is concentration-dependent, and the approved range is maintained because underdosing selects for resistant Eimeria field strains while overdosing narrows the safety margin in broiler flocks. The feed-mill operator must therefore verify that the weigh-hopper load cell calibration, the premix sifter, and the mixer ribbon tip speed are all maintained within specification. Typical ribbon tip speed ranges from 3.0–4.5 m/s. Batch records should state the weighed premix addition, the purge air pressure in the pneumatic transfer line, and the mixer cycle time. Published data for narasin stability in modern no-antibiotic-ever broiler programmes are limited to individual integrator field studies.

What Limits Narasin Recovery in Low-Inclusion Mineral Premixes?

The primary constraint in low-inclusion mineral premixes is not chemical incompatibility but particle-size mismatch between narasin granules and the limestone and dicalcium phosphate macro-mineral fraction. Narasin premix carriers are frequently sized to 250–850 µm to match the mineral fraction, while the technical API is often milled to a D90 below 150 µm. When a premix is prepared at 5 g/kg narasin activity using a coarse limestone carrier, fines migration can produce a stratified vertical profile in bulk silos and a higher assay in the first and last 15 kg of a packed line. The resulting segregation is measured by discharging the mixer into 20 sequential sub-batches and comparing the assay by LC-MS/MS. The coefficient of variation should not exceed 10% for a micro-premix before final dilution. Mineral oil applied at 0.5–1.0% w/w to the carrier before mixing can reduce electrostatic adhesion, but it introduces a risk of granule agglomeration when ambient relative humidity exceeds 60%. An alternative is the use of a rice hull or corn cob fraction that has been dried to 8–10% moisture. In high-humidity tropical mills, pre-drying of the carrier and the API is required before blending. The analytical recovery of narasin from mineral premixes is affected by the extraction pH, because the carboxylic acid form is poorly soluble in water. Extraction with acidified methanol-water at a pH below 3.0 followed by reversed-phase HPLC with post-column derivatisation is the standard approach. Published recovery data for narasin in high-calcium premixes are limited, but the method should be validated for recovery between 90% and 110% across the intended concentration range.

Thermal Conditioning and Pellet Die Retention Time

Across broiler crumble and pellet lines, conditioning temperatures range from 70–85°C with steam addition of 10–15% by mass and residence times of 20–45 s. The mechanical energy input in a pellet die with a compression ratio of 1:8 to 1:11 raises the pellet surface temperature by 5–10°C above the conditioned mash temperature. Narasin activity during pelleting depends on the free acid or sodium salt form, the carrier matrix, and the moisture content of the mash entering the conditioner. Assays from production-scale broiler pellet lines typically report narasin retention above 95% after conditioning at 80°C for 30 s, but these results are matrix-specific and published data for this configuration are limited. The main risk is not thermal degradation but the reaction of narasin with trace metal ions in the pellet die and conditioner wall scale. Acidic carrier components can accelerate the opening of the polyether ring in the presence of iron and copper residues. For this reason, the contact surfaces of the conditioner and die should be cleaned after producing high-mineral or trace-mineral feeds, and the use of a sacrificial flush batch is recommended. The post-pelleting assay is measured at the cooler discharge and at the fat coater discharge. Narasin recovery in fat-coated pellets is typically lower when the fat is added at temperatures above 70°C in the coater because the fat phase can sequester the ionophore during extraction. The extraction procedure for finished feed must therefore include a fat-dissolution step with hexane or petroleum ether before the methanolic extraction. Process capability studies use a minimum of 30 consecutive batches to establish the mean assay and within-batch variability. A process capability index Cpk of at least 1.33 is expected for the pelleted feed assay to remain within the registered in-feed range.

Because the carboxylic acid moiety of narasin has pH-dependent aqueous solubility, the formulation of stable oral solutions or injectable presentations is constrained by the need for a co-solvent system such as methanol, ethanol, or propylene glycol. The free acid is practically insoluble in water while the sodium salt shows moderate solubility at alkaline pH. No commercial injectable narasin product for food-producing animals is widely registered, and the narrow therapeutic index of ionophores would require a full target animal safety evaluation under VICH GL 43 before any parenteral use. Compressed tablet and capsule prototypes are prepared in analytical and toxicological studies using direct compression with microcrystalline cellulose, croscarmellose sodium, and magnesium stearate. Uniformity of such research batches is evaluated by USP <905> with an acceptance value not exceeding 15.0. Powder and granule presentations intended for feed dilution are the only widely used commercial forms. A dry granulation step is sometimes applied to the API to improve flow and reduce dust, using a roller compactor with a roll pressure of 40–80 bar and a screen size of 0.8–1.5 mm. Liquid presentations are generally restricted to analytical reference standards, where narasin is dissolved in methanol at 1 mg/mL and stored at −20°C in amber ampoules to limit photodegradation. For this reason, the specification of narasin as an API for tablets, injections, capsules, powders, granules, premix, and solutions should not be interpreted as regulatory approval for each route; the approved product form is determined by the national feed additive or veterinary medicinal product registration.

When Narasin Is Co-Formulated with Nicarbazin for Shuttle Programs

Co-formulation with nicarbazin changes the shuttle-programme design because the two active substances have different solubility profiles and coccidial spectra. Approved fixed-ratio premixes in some markets are used in starter and grower feeds, with the transition to an ionophore-only product or to a non-ionophore chemical in the finisher phase. The in-feed activity of each component is selected to avoid exceeding the approved maximum for either substance. In shuttle programmes, the nicarbazin-narasin combination is typically followed by narasin alone or by salinomycin in the finisher ration. The rotation is driven by field monitoring of oocyst shedding and by sensitivity testing of Eimeria isolates from broiler litter. Analytical control for a fixed-ratio premix requires separate HPLC quantitation of nicarbazin and narasin because the ultraviolet chromophores are distinct and the extraction conditions for the two substances are not identical. The nicarbazin component is recovered with acetonitrile-water, while narasin requires acidified methanol-water for complete extraction from the same matrix. A single-laboratory validation should demonstrate that the two analytes do not co-elute with the synthetic antioxidants or pigment carriers used in the premix. The co-formulation also alters the physical-mixing behaviour: nicarbazin is supplied as a fine yellow crystalline powder with a tendency to adhere to stainless steel, while narasin premix is often granulated. The divergent particle sizes create a risk of demixing in bulk bins if the combined premix is transferred pneumatically over long distances. Transfer lines should be designed with a maximum conveying air velocity of 18–22 m/s and a minimum bend radius of 10 pipe diameters. Published field data comparing shuttle programmes across different broiler complexes are limited, and the decision to rotate should be based on farm-level oocyst counts rather than on a fixed calendar interval.

Cleaning Validation and Carryover into Non-Target Species Represent a Production Boundary

After a narasin-containing batch is discharged from the mixer or pellet line, residual API becomes a safety issue when the subsequent batch is destined for turkeys, horses, laying hens producing eggs for human consumption, or other non-approved species. Narasin is contraindicated in equids and turkeys because the ionophore disrupts cardiac and skeletal muscle ion gradients at feed concentrations far below the broiler dose. Carryover control is therefore part of medicated feed production under 21 CFR 225.130 and equivalent current good manufacturing practice rules. The flush sequence is validated using a non-medicated carrier such as ground corn or wheat middlings, with the flush volume typically 200–500 kg for a 2–5 tonne horizontal ribbon mixer. After the flush, the absence of narasin is confirmed by LC-MS/MS at a reporting limit of 0.1–0.5 mg/kg in the flush material. Acceptance limits for the next non-medicated batch are set by the mill's hazard analysis, not by a universal regulatory standard. A validated cleaning procedure includes disassembly of the mixer bottom gate, the discharge auger, and the pellet mill conditioner paddles because narasin-containing dust accumulates in dead zones. The use of water wash is generally avoided before dry feed production because residual moisture can cause mould growth and caking in the next batch. Dry wipe-down with compressed air and a sacrificial flush is preferred. The analytical method for carryover should be able to distinguish narasin from the structurally related ionophores monensin, salinomycin, and lasalocid because these substances may be used in different production campaigns. A single-column reversed-phase HPLC method with post-column derivatisation can resolve these ionophores, but the retention time window must be verified with a matrix blank from the non-target species feed. In mills producing both broiler and turkey feeds, the scheduling of narasin-containing batches is separated by at least 2 non-medicated flush batches and a clean-out inspection. Published data for the absolute carryover threshold that is safe for horses are limited, so the operational target is generally set at the analytical reporting limit rather than at a pharmacological no-effect dose.

In tropical feed-mill warehouses where ambient relative humidity exceeds 70%, narasin premix containers must be resealed immediately after withdrawal because the granulated carrier absorbs moisture and the API can migrate to the container walls. The analytical release of narasin premix follows a set of specification methods that are aligned with pharmacopoeial and feed additive requirements. The table below lists typical release parameters and associated standard methods for a granulated premix.

Stability data for narasin premix stored at 25°C/60% RH in a sealed aluminium foil laminate bag typically support a shelf life of 24 months, but the manufacturer's real-time data should be used. At 40°C/75% RH, accelerated testing is conducted for 6 months to confirm the absence of degradation peaks in the HPLC trace. Recertification of material stored under tropical conditions includes re-assay of the active substance and a moisture determination. Published stability data for narasin in multi-layer paper bags under tropical warehouse conditions are limited; end users should therefore confirm the container closure system and the storage temperature before mixing. The disposal of expired narasin premix requires incineration in a licensed facility because the ionophore is not readily degraded by standard wastewater treatment. This operational requirement is part of the environmental risk assessment under local veterinary medicine or feed additive regulations.